Meiogenix
PrivateLast Round
Series B
Oct 30, 2025
Total Funding Raised
$14.6M
Company Overview
Meiogenix operates in Healthcare & Life Sciences and is based in North Carolina. Its latest recorded funding round was a Series A round in December 2021.
Meiogenix is an agriculture biotechnology company that develops a platform for crop improvement using chromosome editing to expand genetic diversity.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Meiogenix Comparables
Compare Meiogenix with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Verinomics | 82% | |
| Pairwise | 81% | |
| Plastomics, Inc. | 79% |
For institutional investors. Book with your work email.
Meiogenix Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Oct 30, 2025 | ||||
| Series A | Dec 14, 2021 | ||||
| Seed | Nov 26, 2010 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Meiogenix Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Genoa Ventures | Series A |
| Alexandria Venture Investments | Series A |
| Sofinnova Partners | Series A |
| Casdin Capital | Series A |
| Bpifrance | Series A |
| Kurma Partners | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 10, 2025
Moved U.S. headquarters to Research Triangle Park from Ithaca, NY.
- Oct 30, 2025
$17M round completed.
For institutional investors. Book with your work email.
Meiogenix Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Meiogenix's valuation, stock price, and market status.
Is Meiogenix a public or private company?
Meiogenix is a private company.
What is the current stock price of Meiogenix?
Meiogenix is a private company, so its shares have no public market price. Caplight tracks Meiogenix's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Meiogenix worth (valuation)?
Valuation information for Meiogenix is not publicly available.
Can I buy Meiogenix stock?
Meiogenix shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Meiogenix's last funding round?
Meiogenix's most recent funding round was Series B on October 30, 2025.
Who are the main investors in Meiogenix?
Key investors in Meiogenix include Sofinnova Partners.
Will Meiogenix IPO soon?
No public IPO plans have been announced for Meiogenix.
How can I track Meiogenix secondary market activity?
Caplight tracks bids, offers, and trades in Meiogenix's shares on secondary markets.